Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2020 Aug 8;48(2):383–394. doi: 10.1007/s00259-020-04978-6

Fig. 5.

Fig. 5

Saturation plots of 89Zr-labeled antibodies to determine binding affinity (Kd). [89Zr]ZrDFO-Amivantamab to EGFR (a) and c-MET (b) proteins, [89Zr]ZrDFO-α-EGFR to EGFR protein (c) and [89Zr]ZrDFO-α-c-MET to c-MET proteins (d) (n = 3 replicates each)